EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis

DeAnna Baker Frost iD, Alisa Savchenko, Naoko Takamura, Bethany Wolf iD, Roselyn Fierkens, Kimberly King, Carol Feghali-Bostwick iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von DeAnna Baker Frost und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 822, MSC 637, …. Hauptthemen laut MEDLINE: Interleukin-6, Estradiol, Fibrosis, Fibroblasts. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCATS NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is characterized by dermal fibrosis with a female predominance, suggesting a hormonal influence. Patients with SSc have elevated interleukin (IL)-6 levels, and post-menopausal women and older men also have high estradiol (E2) levels. In the skin, IL-6 increases the enzymatic activity of aromatase, thereby amplifying the conversion of testosterone to E2. Therefore, we hypothesized that an interplay between E2 and IL-6 contributes to dermal fibrosis. We used primary dermal fibroblasts from healthy donors and patients with diffuse cutaneous (dc)SSc, and healthy donor skin tissues stimulated with recombinant IL-6 and its soluble receptor (sIL-6R) or E2. Primary human dermal fibroblasts and tissues from healthy donors stimulated with IL-6+sIL-6R produced E2, while E2-stimulated dermal tissues and fibroblasts produced IL-6. Primary dermal fibroblasts from healthy donors treated with IL-6+sIL-6R and the aromatase inhibitor anastrozole (ANA) and dcSSc fibroblasts treated with ANA produced less fibronectin (FN), type III collagen A1 (Col IIIA1), and type V collagen A1 (Col VA1). Finally, dcSSc dermal fibroblasts treated with the estrogen receptor inhibitor fulvestrant also generated less FN, Col IIIA1, and Col VA1. Our data show that IL-6 exerts its pro-fibrotic influence in human skin in part through E2 and establish a positive feedback loop between E2 and IL-6.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6EstradiolFibrosisFibroblastsScleroderma, SystemicHumansFemaleMaleSkinCells, CulturedFeedback, PhysiologicalMiddle AgedAdultReceptors, Interleukin-6

Stichwörter der Autor:innen

IL-6aromatasedermal fibrosisestradiolsystemic sclerosis

Substanzen

Interleukin-6EstradiolIL6 protein, humanReceptors, Interleukin-6

Autor:innen und Institutionen

  • Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 822, MSC 637, Charleston, SC 29425, USA.
  • College of Osteopathic Medicine, Rocky Vista University, 4130 Rocky Vista Way, Billings, MT 59106, USA.
  • Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Kanagawa, Japan.
  • Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Room 305F, Charleston, SC 29425, USA.
  • Barabara Davis Center, Department of Pediatrics, University of Colorado, School of Medicine, M20-3201N, 1775 Aurora Court, Aurora, CO 80045, USA.
  • School of Medicine, Morehouse College, 720 Westview Drive, Atlanta, GA 30310, USA.

ORCID-Profile: DeAnna Baker Frost, Bethany Wolf, Carol Feghali-Bostwick

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • NIAMS NIH HHS
  • American College of Rheumatology Research Foundation
  • National Scleroderma Foundation
  • National Scleroderma Foundation New Investigator Award

Zitieren

APA

Baker Frost, D., Savchenko, A., Takamura, N., Wolf, B., Fierkens, R., King, K., & Feghali-Bostwick, C. (2024). A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137227

Vancouver

Baker Frost D, Savchenko A, Takamura N, Wolf B, Fierkens R, King K, et al. A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137227

BibTeX
@article{BakerFrost2024,
  author = {Baker Frost, DeAnna and Savchenko, Alisa and Takamura, Naoko and Wolf, Bethany and Fierkens, Roselyn and King, Kimberly and Feghali-Bostwick, Carol},
  title = {A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137227}
}
Kostenlos starten →